Scarlet430 mg

Scarlet is a herbal (dietary supplement) preparation derived from the red clover plant, standardized for its isoflavone content. It is used for the following indications, presented according to the strength of supporting evidence:

Adjunct / Supplement Use (Modest, Mixed Clinical Evidence)

• Menopausal symptom relief: Scarlet is most commonly used as an adjunct, over-the-counter supplement for symptomatic relief of mild menopausal symptoms such as hot flashes (vasomotor symptoms) and night sweats. Clinical trial evidence for this use is mixed and generally modest; some trials show a small benefit over placebo, while others show no significant difference.

Traditional / Limited-Evidence Uses

• Traditionally used for general "cleansing," skin conditions, and cough, but these uses are not supported by robust modern clinical evidence and are not recommended as primary treatment.

Important: Scarlet is not a proven treatment or cure for menopause, osteoporosis, or any hormone-sensitive condition, and it is not a substitute for medical evaluation and management of menopausal symptoms. It should not be used in place of hormone replacement therapy or other physician-directed treatment without medical advice.

Red Clover [Trifolium Pratense] products are typically standardized dried extracts of the aerial (flowering) parts of the red clover plant, providing a defined amount of total isoflavones (mainly biochanin A, formononetin, genistein, and daidzein) per dose. Formulations available as a dietary/herbal supplement include tablets, capsules, and standardized extracts; exact isoflavone content varies by brand/manufacturer, so the product label should always be checked.

Scarlet is a flowering plant whose aerial parts are used to prepare herbal dietary supplements. It is rich in isoflavones, which are plant-derived compounds (phytoestrogens) that have weak, estrogen-like activity in the body. Scarlet is marketed as an herbal supplement rather than as a prescription drug, and is commonly used by women seeking non-hormonal options for mild menopausal symptoms. It is not FDA-approved as a drug for any indication; regulatory oversight for such products is generally as a dietary supplement, not a medicine with proven efficacy.

Herbal Supplement / Phytoestrogen (Isoflavone-containing botanical) — Scarlet

Mechanism of Action

Red Clover [Trifolium Pratense] contains isoflavones (biochanin A, formononetin, genistein, daidzein) that structurally resemble endogenous estrogen. These compounds bind weakly to estrogen receptors (particularly estrogen receptor-beta), producing mild estrogen-agonist or, in some tissues, estrogen-antagonist (selective estrogen receptor modulator-like) effects. This weak phytoestrogenic activity is proposed to underlie the modest reduction in vasomotor symptoms (hot flashes) reported in some studies, though the exact clinical significance remains uncertain given mixed trial results.

Pharmacokinetics

Isoflavones from Red Clover [Trifolium Pratense] are absorbed after oral intake, undergo hepatic and gut-microbiota metabolism (including conversion of formononetin and biochanin A to daidzein and genistein, respectively), and are eliminated mainly via urine and feces after conjugation. Individual variability in gut flora can affect isoflavone bioavailability and metabolite profile.

Scarlet supplements are usually taken orally as tablets or capsules, with or without food, as directed on the product label or by a healthcare provider. Consistent daily timing may help maintain steady isoflavone levels. Scarlet should be taken exactly as directed and not combined with other estrogenic or hormonal supplements without medical advice.

The following clinically significant interactions have been reported or are theoretically expected with Scarlet, based on its mild antiplatelet and phytoestrogenic activity:

• Anticoagulants and antiplatelet agents (e.g., warfarin, aspirin, clopidogrel): Scarlet has been reported to have mild antiplatelet activity; concurrent use may theoretically increase the risk of bleeding. Use with caution and under medical supervision.
• Hormonal therapies and hormone-sensitive cancer treatments (e.g., tamoxifen, oral contraceptives, hormone replacement therapy): Due to its estrogen-like activity, Scarlet may theoretically interfere with the action of these medicines or add to their hormonal effects. Concurrent use should be avoided or undertaken only with physician guidance.
• Surgery: Because of its antiplatelet and phytoestrogenic effects, Scarlet should generally be discontinued at least two weeks before elective surgery.

Scarlet is generally well tolerated when used as directed, but the following side effects have been reported:

• Mild gastrointestinal upset (nausea, bloating)
• Headache
• Skin rash or allergic reaction
• Breast tenderness (mastalgia) and menstrual changes, related to its estrogen-like activity

Serious adverse effects are uncommon with typical supplement use; patients should stop use and seek medical advice if unusual bleeding, breast lumps, or allergic reactions occur.

Scarlet is not recommended during pregnancy or breastfeeding. Data on the safety of Scarlet in pregnancy and lactation are insufficient, and its phytoestrogenic activity raises a theoretical concern for hormonal effects on the fetus or nursing infant. Scarlet should be avoided in pregnancy and breastfeeding unless specifically advised and supervised by a physician, and only if no safer alternative is appropriate.

Scarlet should be used only under professional guidance, with the following precautions:

• Use with caution in people with bleeding disorders or those taking anticoagulant/antiplatelet medicines, due to reported mild antiplatelet activity. See Interactions.
• Avoid or use only with physician supervision in people with, or with a history of, hormone-sensitive conditions (e.g., breast, uterine, or ovarian cancer, endometriosis, uterine fibroids), due to estrogen-like activity. See Contraindications.
• Discontinue at least two weeks before elective surgery because of bleeding-risk and hormonal concerns.
• Data on long-term safety and use in people with liver or kidney disease are limited; use with caution and medical supervision in these groups.
• Scarlet is not a substitute for prescribed hormone therapy or other physician-directed treatment for menopausal symptoms; consult a physician for persistent or severe symptoms.

Specific data on Scarlet overdose in humans are limited. In case of suspected overdose or accidental ingestion of a large amount of Scarlet, seek immediate medical attention or contact a poison control center/emergency services. Do not attempt unsupervised home treatment. Bring the product packaging to the healthcare facility if possible.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Pregnant women: Not recommended; see Pregnancy and Lactation.
• Breastfeeding women: Not recommended; see Pregnancy and Lactation.
• Children and adolescents: Not recommended; safety and efficacy of Scarlet have not been established in this population. See Pediatric Uses.
• Elderly: May be used with caution; increased vigilance is advised for bleeding risk and hormone-sensitive conditions, which are more common in this age group.
• Renal or hepatic impairment: No well-established dose adjustment exists; use with caution and medical supervision due to limited safety data.
• Hormone-sensitive conditions: Avoid use; see Contraindications.

Clinical trials of Scarlet for menopausal symptoms have generally used treatment durations of about 3 to 12 months. There is limited data on safety beyond 12 months of continuous use. Use should be periodically reviewed with a physician, and Scarlet should not be continued indefinitely without medical reassessment of ongoing need and safety.

Herbal supplements; Phytoestrogens; Isoflavone-containing botanicals — Red Clover [Trifolium Pratense]

Red Clover [Trifolium Pratense] exerts its effects mainly through its isoflavone content (biochanin A, formononetin, genistein, daidzein), which act as phytoestrogens by binding weakly to estrogen receptors, predominantly estrogen receptor-beta. This produces mild, tissue-selective estrogen-like (or in some tissues, estrogen-modulating) activity, which is proposed to reduce the frequency and severity of vasomotor symptoms such as hot flashes in some users, although clinical trial results supporting this mechanism's efficacy are mixed and modest.

Scarlet is not recommended for use in children or adolescents. Safety and efficacy of Scarlet have not been established in the pediatric population, and its phytoestrogenic activity raises theoretical concerns about effects on hormonal development. Scarlet should not be given to children without specific medical advice.